Native state mass spectrometry (MS) has been recognised as a rapid, sensitive and high throughput method to directly investigate protein-ligand interactions for some time, however there are few examples reporting this approach as a screening method to identify relevant protein-fragment interactions in fragment based drug discovery (FBDD). In this paper an overview of native state MS will be presented, highlighting the attractive properties of this method within the context of fragment screening applications. A summary of published examples using MS for fragment screening will be described and reflection on the outlook for the future adoption and implementation of native state MS as a complementary fragment screening method will be presented.
Page 5 of 17 The binding affinity between a protein and small molecule is a combined function of the binding enthalpy and the binding entropy. [21] A knowledge of the differing contribution of enthalpic and entropic interactions upon transfer of noncovalent protein-ligand complexes into the gas phase using ESI-MS is continuing to build, although it is not yet fully understood. [22, 23] Enthalpic interactions, dependent on electrostatic and polar interplay, include hydrogen bonds and Van der Waals interactions and are maximised by an optimal geometric fit between the small molecule and target protein. Enthalpic interactions survive transfer from solution to the gas phase, and are even strengthened in the gas phase. [22, 23] In contrast protein-ligand interactions, dependent primarily on the hydrophobic effect, are weakened in the gas phase to the extent that hydrophobic interactions may not survive transfer from solution to the gas phase. [23] When a mixture of polar and hydrophobic interactions define the solution phase protein-ligand binding recognition, the noncovalent complex is likely to be retained and observed in the gas phase owing to the polar component of the interaction. [22, 23] It has been demonstrated that for improved outcomes in drug discovery that it is an advantage to start from enthalpically-driven leads, as compounds formed by optimising entropy or hydrophobic interactions often result in poorer drug development prospects and increased likelihood of attrition. [21] When studying noncovalent complexes by ESI-MS, it is known that modulating the ionic strength or the addition of co-solvents to the aqueous buffer will affect the hydrophobic effect in solution. [24] As the screening of fragments using ESI-MS may have a bias towards detecting fragments that bind via electrostatic interactions, and bias against those that are predominantly stabilised by hydrophobic interactions it is conceivable that the implications of native state ESI-MS, by favouring the detection of enthalpically driven binding fragments, may be the identification of preferred fragment candidates for follow up development efforts via medicinal chemistry.
Fragment libraries are often prepared and stored as high concentration stock solutions in dimethylsulfoxide (DMSO). For fragment screening by ESI-MS an understanding of the impact
of the presence of DMSO as co-solvent on the electrospray process is needed. DMSO has a higher standard boiling point than water (189 °C compared to 100 °C), a lower vapour pressure than water and does not form an azeotrope with water. [25] During transfer to the gas phase the addition of DMSO to the aqueous protein solution results in (i) preferential evaporation of water from the ESI droplets and enrichment in DMSO, and (ii) an increase in the lifetime of the ESI Page 7 of 17 droplets causing droplet heating. [25, 26] As both high DMSO concentration and heating act to denature a protein it is possible that in the presence of DMSO as a co-solvent proteins could undergo conformational changes during the ESI process resulting in increased charging of the protein. [26] It has been shown that DMSO mediated protein unfolding occurs at around a 3-fold to 5-fold lower DMSO concentration during ESI than it does for protein unfolding in solution. [26] At a level of DMSO that is more likely in fragment screening however (eg. <2% DMSO) a decrease in the average charge of proteins has been observed, indicative of minor compaction of the native protein structure rather than denaturation. Figure 2 shows the nanoESI mass spectra for hen egg white lysozyme (MW = 14.3 kDa) in water at 0%, 2% and 50% DMSO as well as the relationship between protein structure and %DMSO over the full range of 0-100 %DMSO. [26] The ESI-MS findings with DMSO in Figure 2 were consistent with protein structural information provided from the same samples using near UV-CD spectroscopy and solution hydrogen/deuterium exchange MS. [26] While protein unfolding during ESI-MS likely occurs at concentrations of DMSO well above those used for fragment screening, control experiments with the target protein that titrate against any employed co-solvent (DMSO or other) should be carried out to establish a baseline for any impact the co-solvent may have on the electrospray process prior to eventual fragment screening using native state ESI-MS. 
